Last reviewed · How we verify
Methadone Injectable Product
Methadone Injectable Product is a Small molecule drug developed by Pontificia Universidad Catolica de Chile. It is currently FDA-approved. Also known as: Methadone 0, Methadone 1 0,05 mg/kg, Methadone 2 0,1 mg/kg, Methadone 3 0,2 mg/kg.
At a glance
| Generic name | Methadone Injectable Product |
|---|---|
| Also known as | Methadone 0, Methadone 1 0,05 mg/kg, Methadone 2 0,1 mg/kg, Methadone 3 0,2 mg/kg |
| Sponsor | Pontificia Universidad Catolica de Chile |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Symptom-inhibited Fentanyl Induction (PHASE4)
- An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service (PHASE3)
- Intensive Models of HCV Care for Injection Drug Users (NA)
- Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1 (PHASE2)
- Project STAMINA (Syringe Service Telemedicine Access for Medication-assisted Intervention Through NAvigation) (NA)
- Extended-release Pharmacotherapy for Opioid Use Disorder (PHASE3)
- Influence of Aging on Perioperative Methadone Dosing (PHASE4)
- Effect of Heroin Use on Immune Activation and Cardiovascular Risk in HIV
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Methadone Injectable Product CI brief — competitive landscape report
- Methadone Injectable Product updates RSS · CI watch RSS
- Pontificia Universidad Catolica de Chile portfolio CI
Frequently asked questions about Methadone Injectable Product
What is Methadone Injectable Product?
Methadone Injectable Product is a Small molecule drug developed by Pontificia Universidad Catolica de Chile.
Who makes Methadone Injectable Product?
Methadone Injectable Product is developed and marketed by Pontificia Universidad Catolica de Chile (see full Pontificia Universidad Catolica de Chile pipeline at /company/pontificia-universidad-catolica-de-chile).
Is Methadone Injectable Product also known as anything else?
Methadone Injectable Product is also known as Methadone 0, Methadone 1 0,05 mg/kg, Methadone 2 0,1 mg/kg, Methadone 3 0,2 mg/kg.
What development phase is Methadone Injectable Product in?
Methadone Injectable Product is FDA-approved (marketed).
Related
- Manufacturer: Pontificia Universidad Catolica de Chile — full pipeline
- Also known as: Methadone 0, Methadone 1 0,05 mg/kg, Methadone 2 0,1 mg/kg, Methadone 3 0,2 mg/kg
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing